Search by Drug Name or NDC
NDC 00121-0581-15 Haloperidol 2 mg/mL Details
Haloperidol 2 mg/mL
Haloperidol is a ORAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PAI Holdings, LLC. The primary component is HALOPERIDOL.
MedlinePlus Drug Summary
Haloperidol is used to treat psychotic disorders (conditions that cause difficulty telling the difference between things or ideas that are real and things or ideas that are not real). Haloperidol is also used to control motor tics (uncontrollable need to repeat certain body movements) and verbal tics (uncontrollable need to repeat sounds or words) in adults and children who have Tourette's disorder (condition characterized by motor or verbal tics). Haloperidol is also used to treat severe behavioral problems such as explosive, aggressive behavior or hyperactivity in children who cannot be treated with psychotherapy or with other medications. Haloperidol is in a group of medications called conventional antipsychotics. It works by decreasing abnormal excitement in the brain.
Related Packages: 00121-0581-15Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Haloperidol
Product Information
| NDC | 00121-0581 |
|---|---|
| Product ID | 0121-0581_da2ea885-9583-4475-b0ae-6683825a7587 |
| Associated GPIs | 59100010201305 |
| GCN Sequence Number | 003971 |
| GCN Sequence Number Description | haloperidol lactate ORAL CONC 2 MG/ML ORAL |
| HIC3 | H7O |
| HIC3 Description | ANTIPSYCHOTICS,DOPAMINE ANTAGONISTS,BUTYROPHENONES |
| GCN | 15520 |
| HICL Sequence Number | 001661 |
| HICL Sequence Number Description | HALOPERIDOL LACTATE |
| Brand/Generic | Generic |
| Proprietary Name | Haloperidol |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Haloperidol |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 2 |
| Active Ingredient Units | mg/mL |
| Substance Name | HALOPERIDOL |
| Labeler Name | PAI Holdings, LLC |
| Pharmaceutical Class | Typical Antipsychotic [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA073037 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00121-0581-15 (00121058115)
| NDC Package Code | 0121-0581-15 |
|---|---|
| Billing NDC | 00121058115 |
| Package | 15 mL in 1 BOTTLE (0121-0581-15) |
| Marketing Start Date | 2020-06-12 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 1.12169 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | HALOPERIDOL LAC 2 MG/ML CONC |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |